Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.

Pharmaceutical

Umoja Biopharma

Umoja Biopharma's headquarters in Seattle, WA, United States

Andy Scharenberg

Nate Hardy

David Fontana

Tonya Swick

Ryan Crisman

Michael Jensen

Luke Evnin

Phil Low

Rimas Orentas

John Hamer

Anna French

Franklin M. Berger

Hans-Peter Kiem

Rob Glassman

The Research and Development team at Umoja Biopharma is tasked with innovating and refining novel cancer therapies by leveraging the body's own immune system. Comprising senior scientists and principal researchers, the team conducts cutting-edge research to enhance allogeneic cell therapy processes, develop in vivo solutions, and analyze therapeutic outcomes for effective cancer treatment.

Research and Development

This department focuses on managing clinical operations and engineering processes to ensure efficient program execution and alliance management.

Clinical and Engineering Operations

This department is responsible for ensuring that products meet quality standards through rigorous testing and analysis.

Quality Control

This department is responsible for the research and development of pharmaceutical products and processes.

Drug Development

This department focuses on ensuring that products meet quality standards and function correctly through testing and validation processes.

Quality Assurance

This department focuses on advancing knowledge and innovation through scientific research and experimentation.

Umoja Biopharma

Org chart

Board & advisors

Teams

Research and Development

Clinical and Engineering Operations

Quality Control

Drug Development

Quality Assurance

Research Development

Offices

Umoja Biopharma

Org chart

Board & advisors

Teams

Research and Development

Clinical and Engineering Operations

Quality Control

Drug Development

Quality Assurance

Research Development

Offices

Related companies